Lantern Pharma Inc. (LTRN) Stock Price

2.51 ▼ -0.09 (-3.46%)
Open: 2.58 Vol: 35.76K Day's range: 2.51 - 2.7697 Jul 29, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
LTRN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.61▼ 2.61▼ 2.62▼ 2.70▼ 3.14▼
MA10 2.63▼ 2.64▼ 2.65▼ 2.80▼ 3.44▼
MA20 2.68▼ 2.71▼ 2.72▼ 3.16▼ 2.85▼
MA50 2.76▼ 2.80▼ 2.82▼ 3.47▼ 3.26▼
MA100 2.84▼ 2.93▼ 3.03▼ 2.85▼ 3.50▼
MA200 2.97▼ 3.29▼ 3.45▼ 3.12▼ 4.22▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.005▼ -0.009▼ -0.010▼ -0.068▼ -0.027▼
RSI 34.087▼ 35.754▼ 35.899▼ 31.949▼ 42.145▼
STOCH 22.222     15.298▼ 14.753▼ 6.269▼ 40.631    
WILL %R -100.000▼ -100.000▼ -100.000▼ -100.000▼ -76.891▼
CCI -156.164▼ -134.978▼ -122.572▼ -122.804▼ -77.105    
Latest Filters Detected On LTRN
▼ BREAK $LTRN Price Breaks 30 Days Low Set Alert
▼ BREAK $LTRN Price Breaks 20 Days Low Set Alert
▼ BREAK $LTRN Price Breaks 10 Days Low Set Alert
Lantern Pharma Inc. News
Biomednewsbreaks - Lantern Pharma (NASDAQ: LTRN) EMA Clears LP-184 Bladder Cancer Trial In Europe
Tuesday, July 28, 2026 03:03 AM
EMA Clears LP-184 Bladder Cancer Trial In Europe. Lantern Pharma (NASDAQ: LTRN) an AI-native precision oncology company, announced that the European Medicines Agency (“EMA”) has cleared an investigato ...
Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer
Monday, July 27, 2026 05:00 PM
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company using its proprietary RADR® artificial intelligence and machine-learning platform to develop precision oncology ...
Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers
Thursday, July 23, 2026 05:01 AM
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using artificial intelligence and genomic data to develop targeted cancer therapies, today announced that the United ...
LTRN historical stock data
date open high low close volume
29/07/26 2.58 2.7697 2.51 2.51 35,756
28/07/26 2.79 2.8408 2.60 2.60 64,827
27/07/26 2.77 2.90 2.7589 2.79 38,323
24/07/26 2.87 2.885 2.73 2.75 63,641
23/07/26 2.80 2.93 2.72 2.87 85,483
22/07/26 2.90 2.955 2.83 2.84 45,504
21/07/26 2.97 3.05 2.8722 2.94 126,015
20/07/26 2.86 3.0637 2.86 2.95 59,358
17/07/26 2.85 3.05 2.80 2.87 106,237
16/07/26 3.01 3.08 2.91 2.91 265,434
Quote Details
52wk Low:1.11
52wk High:5.744
Vol:35.76K
Avg Vol(3m):4.4M
1Y Chng:-45.08%
1M Chng:-35.81%
Add to Watch List
More Information
Index US Composite
Market Cap. 33.17M